Cancer News and Research

Latest Cancer News and Research

Three-drug therapy with autologous stem cell transplant improves progression-free survival for multiple myeloma patients

Patients with multiple myeloma who have been treated with a three-drug combination therapy have a growing number of choices for subsequent treatment. Results of a new study led by researchers at Dana-Farber Cancer Institute can help patients and their physicians weigh benefits and risks of each option.

6 Jun 2022

Poor sleep, screen time, alcohol and tobacco use increased among Australian teens after the pandemic

Australian teens had overall improvements in sleep over the two years and some improvements in dietary choices during lockdown, however these were offset by increases in already concerning levels of screen time and worrying trends of alcohol use and poor sleep among girls.

6 Jun 2022

Diabetes-tailored program produces meaningful effects on glycemic control, body weight

Study results from three clinical trial sites show that a WW International, Inc. ("WeightWatchers" or "WW") program tailored for people living with diabetes helped participants lose weight, lower blood glucose levels, and improve their overall well-being.

6 Jun 2022

Chemo-immunotherapy combination shows promise against pancreatic cancer

A combination of chemotherapy with an immunotherapy meant to unleash the anticancer capacity of the immune system was effective against one of the hardest targets in cancer care, pancreatic cancer, in a national, randomized clinical trial led by researchers at the Perelman School of Medicine at the University of Pennsylvania, and sponsored by the Parker Institute for Cancer Immunotherapy.

6 Jun 2022

Children with leukemia have higher survival than adolescents and young adults with the same cancer

Children (0-14 years) diagnosed with leukemia have benefited from decades of research to improve outcomes, and their five-year survival has increased more than that of adolescents (15-19 years) and young adults (20-24 years), suggests new research published in The Lancet Child and Adolescent Health.

6 Jun 2022

Electronic symptom monitoring improved quality-of-life outcomes among patients with metastatic cancer

People with advanced cancer who communicated their symptoms weekly using an electronic survey had about a one-third better physical function and over a 15% better control of their symptoms compared to those who were evaluated less frequently via in-person clinical visits, according to findings from a multi-state study conducted at 52 community cancer clinics.

6 Jun 2022

Hospice patients with dementia more likely to receive excellent care, study shows

While the hospice program was originally designed for patients with cancer, who are expected to die within six months, currently close to half of older adult hospice enrollees have a diagnosis of dementia.

6 Jun 2022

Addition of menthol to cigarettes increases smoking frequency and nicotine dependency among youth

Currently in the public comment phase, the United States Food and Drug Administration is set to finalize rules prohibiting menthol in tobacco products, citing an effort to reduce addiction and youth experimentation, improve quitting among current smokers and address health disparities.

6 Jun 2022

Drug combination yields highest response and longest survival rates for patients with pancreatic NETs

Very few treatment options are available to patients with advanced pancreatic neuroendocrine tumors (NETs), but researchers at the Yale Cancer Center and Yale New Haven Health's Smilow Cancer Hospital found that patients treated with a combination of capecitabine and temozolomide had longer progression-free survival rates than those treated with temozolomide alone.

6 Jun 2022

New analytical method sheds light on enduring mystery about type 2 diabetes

Researchers at Oregon State University have invented a new analytical method that sheds light on an enduring mystery regarding type 2 diabetes: Why some obese patients develop the disease and others don't.

6 Jun 2022

Dotmatics Strengthens Leadership Team as it Continues to Invest in Organization Capabilities and Accelerate Growth

Dotmatics, the leader in R&D scientific software connecting science, data, and decision-making, today announced the addition of Larry Samuelson as Chief Legal Officer and Neil Frye as Chief People Officer. The appointments further bolster the company’s executive team as the company extends the reach of its research and data solutions globally.

From Dotmatics 6 Jun 2022

Study confirms the benefits of 'bridge therapy' for some children with high-risk neuroblastoma

Approximately half of children with neuroblastoma - a childhood cancer that develops from immature nerve cells - have a form that indicates a high likelihood of recurrence.

6 Jun 2022

New trial examines the effectiveness of combination immunotherapy for platinum-resistant ovarian cancer

A new clinical trial studying the effectiveness of a combination of immunotherapy treatments could be more effective for patients with ovarian cancer who are resistant to traditional interventions.

6 Jun 2022

Long-term exposure to air pollution associated with greater risk of severe COVID-19

Long-term exposure to air pollution is linked to a greater risk of severe COVID-19, new research being presented at Euroanaesthesia, the annual meeting of the European Society of Anaesthesiology and Intensive Care (ESAIC) in Milan, Italy (4-6 June), finds.

6 Jun 2022

She’s 31, has stage 4 kidney cancer — and talked openly about it in a job interview

Katie Coleman stood face-to-face with a choice no job seeker should ever have to make. She could tell her prospective employer she had stage 4 kidney cancer, the most life-threatening stage of all.

6 Jun 2022

Addressing the ‘trust factor’: South Carolina researchers tackle health disparities using genetics

Quenton Tompkins' family tree is deeply rooted in rural McCormick County, South Carolina.

6 Jun 2022

COVID-19's economic impact on healthcare systems, societies, and the population

In a recent study review posted to the medRxiv* preprint server, researchers evaluated the economic and medical costs incurred due to the coronavirus disease 2019 (COVID-19) pandemic.

6 Jun 2022

Trial of peptide-centered SARS-CoV-2 T-cell activator in B-cell deficient individuals

A recent phase 1/2 study under review at the Nature Portfolio journal and posted to the Research Square* preprint server demonstrated that a peptide-centered severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) T-cell activator, CoVac-1, was efficient in B-cell deficient people.

6 Jun 2022

Taking everolimus post-surgery can improve outcomes in patients with high-risk renal cell carcinoma

In a study of patients with high-risk renal cell carcinoma, those who took the drug everolimus daily for up to one year after surgery lived longer without their disease returning (recurrence-free survival, or RFS) than those who did not take everolimus, although the results narrowly missed the clinical trial's prespecified level for statistical significance.

4 Jun 2022

Using DNA droplets for early disease detection

Aqueous droplet formation by liquid-liquid phase separation (or coacervation) in macromolecules is a hot topic in life sciences research.

3 Jun 2022

Cancer News and Research

Latest Cancer News and Research

Three-drug therapy with autologous stem cell transplant improves progression-free survival for multiple myeloma patients

Poor sleep, screen time, alcohol and tobacco use increased among Australian teens after the pandemic

Diabetes-tailored program produces meaningful effects on glycemic control, body weight

Chemo-immunotherapy combination shows promise against pancreatic cancer

Children with leukemia have higher survival than adolescents and young adults with the same cancer

Electronic symptom monitoring improved quality-of-life outcomes among patients with metastatic cancer

Hospice patients with dementia more likely to receive excellent care, study shows

Addition of menthol to cigarettes increases smoking frequency and nicotine dependency among youth

Drug combination yields highest response and longest survival rates for patients with pancreatic NETs

New analytical method sheds light on enduring mystery about type 2 diabetes

Dotmatics Strengthens Leadership Team as it Continues to Invest in Organization Capabilities and Accelerate Growth

Study confirms the benefits of 'bridge therapy' for some children with high-risk neuroblastoma

New trial examines the effectiveness of combination immunotherapy for platinum-resistant ovarian cancer

Long-term exposure to air pollution associated with greater risk of severe COVID-19

She’s 31, has stage 4 kidney cancer — and talked openly about it in a job interview

Addressing the ‘trust factor’: South Carolina researchers tackle health disparities using genetics

COVID-19's economic impact on healthcare systems, societies, and the population

Trial of peptide-centered SARS-CoV-2 T-cell activator in B-cell deficient individuals

Taking everolimus post-surgery can improve outcomes in patients with high-risk renal cell carcinoma

Using DNA droplets for early disease detection

Understanding the DNA Damage Response in Innate Immunity eBook

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Cancer News and Research

Latest Cancer News and Research

Understanding the DNA Damage Response in Innate Immunity eBook

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Newsletters you may be interested in